Payment overview · 2025
General Payments
$82.74
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mark Rohrer, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · FOREST CITY, NC · NPI 1750434940
Verified facts
What the public records show
CMS Open Payments records show Mark Rohrer, MD received $82.74 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $82.74 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $82.74 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $82.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 585 | 82 |
| Lisinopril | Lisinopril | 566 | 78 |
| Atorvastatin Calcium | Atorvastatin Calcium | 548 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 493 | 70 |
| Eliquis | Apixaban | 489 | 52 |
| Gabapentin | Gabapentin | 469 | 55 |
| Levothyroxine Sodium | Levothyroxine Sodium | 303 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 253 | 29 |
| Mirtazapine | Mirtazapine | 229 | 22 |
| Potassium Chloride | Potassium Chloride | 229 | 35 |
| Torsemide | Torsemide | 201 | 32 |
| Trazodone Hcl | Trazodone Hcl | 200 | 52 |
| Sertraline Hcl | Sertraline Hcl | 197 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 191 | 43 |
| Spironolactone | Spironolactone | 186 | 37 |
| Losartan Potassium | Losartan Potassium | 178 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 173 | 31 |
| Allopurinol | Allopurinol | 167 | 23 |
| Buspirone Hcl | Buspirone Hcl | 165 | 25 |
| Furosemide | Furosemide | 164 | 33 |
| Memantine Hcl | Memantine Hcl | 157 | 18 |
| Metformin Hcl | Metformin Hcl | 155 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 151 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 150 | 26 |
| Famotidine | Famotidine | 143 | 24 |
| Lorazepam | Lorazepam | 136 | 30 |
| Carvedilol | Carvedilol | 132 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 24 |
| Tramadol Hcl | Tramadol Hcl | 128 | 33 |
| Divalproex Sodium | Divalproex Sodium | 124 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 121 | 23 |
| Oxycodone Hcl | Oxycodone Hcl | 114 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 104 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 103 | 16 |
| Donepezil Hcl | Donepezil Hcl | 103 | 18 |
| Trulicity | Dulaglutide | 102 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 94 | 14 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 93 | 93 |
| Myrbetriq | Mirabegron | 92 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 90 | 26 |
| Omeprazole | Omeprazole | 83 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 81 | suppressed |
| Bumetanide | Bumetanide | 79 | 14 |
| Valsartan | Valsartan | 79 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 73 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 64 | suppressed |
| Risperidone | Risperidone | 64 | suppressed |
| Jardiance | Empagliflozin | 61 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 60 | suppressed |
| Finasteride | Finasteride | 60 | suppressed |
| Xarelto | Rivaroxaban | 59 | suppressed |
| Olanzapine | Olanzapine | 58 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 57 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | 11 |
| Simvastatin | Simvastatin | 54 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 52 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 52 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 52 | suppressed |
| Tivicay | Dolutegravir Sodium | 52 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 50 | suppressed |
| Prednisone | Prednisone | 50 | 27 |
| Linzess | Linaclotide | 49 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 44 | 11 |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 41 | suppressed |
| Januvia | Sitagliptin Phosphate | 40 | suppressed |
| Aripiprazole | Aripiprazole | 39 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 32 |
| Nystatin | Nystatin | 38 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Lactulose | Lactulose | 37 | 12 |
| Oxcarbazepine | Oxcarbazepine | 35 | suppressed |
| Ranolazine Er | Ranolazine | 35 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Digoxin | Digoxin | 34 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | 14 |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 30 | suppressed |
| Sucralfate | Sucralfate | 30 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 24 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Cephalexin | Cephalexin | 27 | 23 |
| Ibuprofen | Ibuprofen | 27 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 26 | 12 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 26 | suppressed |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 21 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 24 | 18 |
| Latanoprost | Latanoprost | 24 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Amantadine | Amantadine Hcl | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 22 | suppressed |
| Ketoconazole | Ketoconazole | 22 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Atenolol | Atenolol | 21 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 17 |
| Meloxicam | Meloxicam | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 14 |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Anastrozole | Anastrozole | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Lacosamide | Lacosamide | 17 | suppressed |
| Mesalamine Dr | Mesalamine | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Budesonide | Budesonide | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 16 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 16 | suppressed |
| Nystop | Nystatin | 16 | 12 |
| Promethazine Hcl | Promethazine Hcl | 16 | 15 |
| Restasis | Cyclosporine | 16 | suppressed |
| Cartia Xt | Diltiazem Hcl | 15 | suppressed |
| Febuxostat | Febuxostat | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Scopolamine | Scopolamine | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $82.74 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error